Puerarin reduces increased c-fos, c-jun, and type IV collagen expression caused by high glucose in glomerular

Cai-ping Mao1, Zhen-lun Gu

  • 1Department of Pharmacology, Suzhou Institute of Chinese Materia Medica,Medical College of Soochow University, Suzhou 215007, China.

Abstract

Insights

Puerarin treatment reduced high glucose-induced increases in c-fos, c-jun, and type IV collagen in kidney cells. This therapeutic effect in diabetic nephropathy may involve decreased protein kinase C activity.

Area of Science:

  • Nephrology
  • Endocrinology
  • Molecular Biology

Background:

  • Diabetic nephropathy is characterized by increased expression of c-fos, c-jun, and type IV collagen (CoIV) in glomerular mesangial cells (GMC).
  • c-fos and c-jun regulate extracellular matrix gene expression, with CoIV being a primary component.
  • Puerarin has shown potential in inhibiting extracellular matrix aggregation in diabetic rats via an unclear mechanism.

Purpose of the Study:

  • To investigate the effects of puerarin on c-fos, c-jun, and CoIV expression in GMC.
  • To explore the role of protein kinase C (PKC) activity in puerarin's mechanism of action.

Main Methods:

  • Quantification of c-fos and c-jun protein levels using flow cytometry.
  • Measurement of CoIV content via radioimmunoassay.
  • Assessment of PKC activity using liquid scintillation counting.

Main Results:

  • Puerarin (10^-5 mmol/L) significantly counteracted high glucose-induced increases in c-fos, c-jun, and CoIV expression in GMC.
  • The ameliorating effect of puerarin was associated with a reduction in cellular PKC activity.

Conclusions:

  • Reduced PKC activity and decreased expression of c-fos and c-jun in GMC appear to be involved in puerarin's therapeutic effects.
  • These findings suggest a potential mechanism for puerarin in managing diabetic nephropathy.